nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
|
Russell, James |
|
|
100 |
4 |
p. 1049-1058 |
artikel |
2 |
Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)
|
Zettl, Florian |
|
|
100 |
4 |
p. 1031-1038 |
artikel |
3 |
Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort
|
Hatzlhofer, Betânia Lucena Domingues |
|
|
100 |
4 |
p. 921-931 |
artikel |
4 |
Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
|
Bernard, S. |
|
|
100 |
4 |
p. 979-986 |
artikel |
5 |
Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis
|
Hu, Linhui |
|
|
100 |
4 |
p. 1003-1012 |
artikel |
6 |
CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma
|
Au-Yeung, Rex |
|
|
100 |
4 |
p. 1101-1104 |
artikel |
7 |
Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients
|
Cao, Xin |
|
|
100 |
4 |
p. 995-1002 |
artikel |
8 |
Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis
|
Modi, Dipenkumar |
|
|
100 |
4 |
p. 969-978 |
artikel |
9 |
Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients
|
Hatairaktham, Suneerat |
|
|
100 |
4 |
p. 891-901 |
artikel |
10 |
Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80—results from a single-center survey
|
Freudenberger, Felix |
|
|
100 |
4 |
p. 1013-1021 |
artikel |
11 |
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group
|
Vozella, Federico |
|
|
100 |
4 |
p. 1059-1063 |
artikel |
12 |
Dynamic evaluation of the prognostic value of 18F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type
|
Xu, Pengpeng |
|
|
100 |
4 |
p. 1039-1047 |
artikel |
13 |
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series
|
Martynova, Anastasia |
|
|
100 |
4 |
p. 933-939 |
artikel |
14 |
Frequent occurrence of hypophosphatemia among multiple myeloma patients treated with elotuzumab: a single clinic retrospective study
|
Regidor, Bernard |
|
|
100 |
4 |
p. 1079-1085 |
artikel |
15 |
Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants
|
Mendoza, Eugenia |
|
|
100 |
4 |
p. 879-890 |
artikel |
16 |
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration
|
Ruhe, Johannes |
|
|
100 |
4 |
p. 1087-1088 |
artikel |
17 |
Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort
|
Batista, Jéssica V. G. F. |
|
|
100 |
4 |
p. 903-911 |
artikel |
18 |
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients
|
González-Barca, Eva |
|
|
100 |
4 |
p. 1023-1029 |
artikel |
19 |
Numb chin syndrome in sickle cell disease: a case series of Jamaican patients
|
Ramsay, Zachary |
|
|
100 |
4 |
p. 913-919 |
artikel |
20 |
Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation
|
Pegoraro, Francesco |
|
|
100 |
4 |
p. 865-878 |
artikel |
21 |
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort
|
Bouclet, Florian |
|
|
100 |
4 |
p. 987-993 |
artikel |
22 |
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)
|
Eisfeld, Hannah |
|
|
100 |
4 |
p. 1107-1109 |
artikel |
23 |
Risk factors for monoclonal gammopathy of undetermined significance: a systematic review
|
Castaneda-Avila, Maira A. |
|
|
100 |
4 |
p. 855-863 |
artikel |
24 |
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis
|
Lucijanic, Marko |
|
|
100 |
4 |
p. 1105-1106 |
artikel |
25 |
Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children’s institution
|
Yuan, Qing |
|
|
100 |
4 |
p. 1093-1095 |
artikel |
26 |
Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting
|
Sahu, Kamal Kant |
|
|
100 |
4 |
p. 1089-1091 |
artikel |
27 |
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study
|
Iida, Shinsuke |
|
|
100 |
4 |
p. 1065-1077 |
artikel |
28 |
Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome
|
Yasunaga, Megumi |
|
|
100 |
4 |
p. 1097-1100 |
artikel |
29 |
Temporal trends and outcome of splenectomy in adults with immune thrombocytopenia in the USA
|
Finianos, Antoine |
|
|
100 |
4 |
p. 941-952 |
artikel |
30 |
The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine
|
Akimoto, Masahiro |
|
|
100 |
4 |
p. 953-957 |
artikel |
31 |
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
|
Schuler, Esther |
|
|
100 |
4 |
p. 959-968 |
artikel |
32 |
Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
|
Zappasodi, P. |
|
|
100 |
4 |
p. 1111-1113 |
artikel |